Rivaroxaban Alternatives Compared
Rivaroxaban | Wegovy | Simvastatin |
|
---|
Rivaroxaban | Wegovy (semaglutide) | Simvastatin |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Atrial Fibrillation, Cardiovascular Risk Reduction, Coronary Artery Disease, Congenital Heart Disease, Deep Vein Thrombosis, Deep Vein Thrombosis Prophylaxis after Hip Replacement... View more |
Prescription only
Prescribed for Weight Loss (Obesity/Overweight), Cardiovascular Risk Reduction. Wegovy may also be used for purposes not listed in this medication guide. |
Prescription only
Simvastatin is effective at lowering cholesterol; however, it may cause muscle pain, particularly at higher dosages. Should not be used by people with active liver disease or in women planning a... View more |
Related suggestions Cardiovascular Risk Reduction
|
|||||||||||||||
More about Rivaroxaban | More about Wegovy (semaglutide) | More about Simvastatin | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Rivaroxaban has an average rating of 5.4 out of 10 from a total of 246 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 42% reported a negative effect. |
Wegovy has an average rating of 7.4 out of 10 from a total of 403 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 18% reported a negative effect. |
Simvastatin has an average rating of 4.8 out of 10 from a total of 129 ratings on Drugs.com. 31% of reviewers reported a positive effect, while 50% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
Lower cost generic |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Wegovy prices |
View all Simvastatin prices |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
N/A |
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Xarelto | Other semaglutide brands include: Ozempic, Rybelsus | FloLipid, Zocor | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
13 hours |
168 hours |
N/A |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 376 drugs are known to interact with Rivaroxaban:
|
A total of 266 drugs are known to interact with Wegovy:
|
A total of 319 drugs are known to interact with Simvastatin:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
July 01, 2011 |
N/A |
December 23, 1991 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
|
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.